Nutritional and Hormonal Modulation of Adiponectin and its Receptors adipoR1 and adipoR2

Vitamins and Hormones

Volumn 90, Issue , 2012, Pages 57-94

  de Oliveira, Cristiane ^a   de Mattos, Ana Barbosa Marcondes ^b   Silva, Carolina Biz Rodrigues ^c   Mota, João Felipe ^d   Zemdegs, Juliane Costa Silva ^c  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Adiponectin; AdipoR1; AdipoR2; Adrenal hormones; Androgens hormones; Carbohydrate; Fatty acid; Growth hormone; Insulin; Thyroid hormones; Vitamin

Indexed keywords

EID: 84866629583     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398313-8.00003-8     Document Type: Chapter

References (244)

1. Ahima R.S., Qi Y., Singhal N.S., Jackson M.B., Scherer P.E. Brain adipocytokine action and metabolic regulation. Diabetes 2006, 55(Suppl. 2):145-554.
2. Al-Sarraj T., Saadi H., Calle M.C., Volek J.S., Fernandez M.L. Carbohydrate restriction, as a first-line dietary intervention, effectively reduces biomarkers of metabolic syndrome in Emiratiadults. The Journal of Nutrition 2009, 139:1667-1676.
3. Altinova A.E., Törüner F.B., Aktürk M., Bukan N., Cakir N., Ayvaz G., et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clinical Endocrinology 2006, 65(4):530-535.
4. Alzamendi A., Giovambattista A., Raschia A., Madrid V., Gaillard R.C., Rebolledo O., et al. Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats. Endocrine 2009, 35:227-232.
5. Andrews R.C., Walker B.R. Glucocorticoids and insulin resistance: Old hormones, new targets. Clinical Science (London, England) 1999, 96(5):513-523.
6. Aragão C.N., Souza L.L., Cabanelas A., Oliveira K.J., Pazos-Moura C.C. Effect of experimental hypo and hyperthyroidism on serum adiponectin. Metabolism 2007, 56(1):6-11.
7. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999, 257(1):79-83.
8. Asai-Sato M., Okamoto M., Endo M., Yoshida H., Murase M., Ikeda M., et al. Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes. Endocrine Journal 2006, 53(4):555-562.
9. Ashizawa N., Takagi M., Seto S., Suzuki S., Yano K. Serum adiponectin and leptin in a patient with Cushing's syndrome before and after adrenalectomy. Internal Medicine 2007, 46:383-385.
10. Azzi A., Gysin R., Kempná P., Munteanu A., Villacorta L., Visarius T., et al. Regulation of gene expression by alpha-tocopherol. Biological Chemistry 2004, 385(7):585-591.
11. Banga A., Unal R., Tripathi P., Pokrovskaya I., Owens R.J., Kern P.A., et al. Adiponectin translation is increased by the PPAR agonists pioglitazone and ω-3 fatty acids. American Journal of Physiology. Endocrinology and Metabolism 2009, 296:E480-E489.
12. Barnea M., Shamay A., Stark A.H., Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity 2006, 14:2145-2153.
13. Basu A., Du M., Sanchez K., Leyva M.J., Betts N.M., Blevins S., et al. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2010, 27:206-213.
14. Bellia A., Garcovich C., D'Adamo M., Lombardo M., Tesauro M., Donadel G., et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Internal and Emergency Medicine 2011, 2011 Mar 25.
15. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001, 7(8):947-953.
16. Berk E.S., Kovera A.J., Boozer C.N., Pi-Sunyer F.X., Johnson J.A., Albu J.B. Adiponectin levels during low- and high-fat eucaloric diets in lean and obese women. Obesity Research 2005, 13:1566-1571.
17. Berner H.S., Lyngstadaas S.P., Spahr A., Monjo M., Thommesen L., Drevon C.A., et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004, 35:842-849.
18. Beulens J.W., Rimm E.B., Hu F.B., Hendriks H.F., Mukamal K.J. Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women. Diabetes Care 2008, 31:2050-2055.
19. Beylot M., Pinteur C., Peroni O. Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Metabolism 2006, 55(3):396-401.
20. Blair S.C., Caterson I.D., Cooney G.J. Glucose tolerance and insulin secretion after adrenalectomy in mice made obese with gold thioglucose. The Journal of Endocrinology 1996, 148:391-398.
21. Bonnard C., Durand A., Vidal H., Rieusset J. Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice. Diabetes & Metabolism 2008, 34(1):52-61.
22. Bossowski A., Sawicka B., Szalecki M., Koput A., Wysocka J., Zelazowska-Rutkowska B. Analysis of serum adiponectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders. Journal of Pediatric Endocrinology & Metabolism 2010, 23(4):369-377.
23. Botella-Carretero J.I., Alvarez-Blasco F., Sancho J., Escobar-Morreale H.F. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid 2006, 16(4):397-402.
24. Bottner A., Kratzsch J., Muller G., Kapellen T.M., Bluher S., Keller E., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. The Journal of Clinical Endocrinology and Metabolism 2004, 89:4053-4061.
25. Boullu-Ciocca S., Achard V., Tassistro V., Dutour A., Grino M. Postnatal programming of glucocorticoid metabolism in rats modulates high-fat diet-induced regulation of visceral adipose tissue glucocorticoid exposure and sensitivity and adiponectin and proinflammatory adipokines gene expression in adulthood. Diabetes 2008, 57:669-677.
26. Brandebourg T., Hugo E., Ben-Jonathan N. Adipocyte prolactin: Regulation of release and putative functions. Diabetes, Obesity & Metabolism 2007, 9(4):464-476.
27. Brien S.E., Ronksley P.E., Turner B.J., Mukamal K.J., Ghali W.A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. British Medical Journal 2011, 342:d636. 10.1136/bmj.d636.
28. Bruns C.M., Kemnitz J.W. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR Journal 2004, 45(2):160-169.
29. Bueno A.A., Oyama L.M., de Oliveira C., Pisani L.P., Ribeiro E.B., Silveira V.L., et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. Pflügers Archiv 2008, 455:701-709.
30. Bullen J.W., Bluher S., Kelesidis T., Mantzoros C.S. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. American Journal of Physiology. Endocrinology and Metabolism 2007, 292:1079-1086.
31. Cabanelas A., Cordeiro A., Santos Almeida N.A., Monteiro de Paula G.S., Coelho V.M., Ortiga-Carvalho T.M., et al. Effect of triiodothyronine on adiponectin expression and leptin release by white adipose tissue of normal rats. Hormone and Metabolic Research 2010, 42(4):254-260.
32. Caixàs A., Tirado R., Vendrell J., Gallart L., Megía A., Simón I., et al. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters. Clinical Endocrinology 2009, 71(5):733-738.
33. Caminos J.E., Nogueiras R., Gallego R., Bravo S., Tovar S., Garcia-Caballero T., et al. Expression and regulation of adiponectin and receptor in human and rat placenta. The Journal of Clinical Endocrinology and Metabolism 2005, 90:4276-4286.
34. Caminos J.E., Nogueiras R., Gaytán F., Pineda R., González C.R., Barreiro M.L., et al. Novel expression and direct effects of adiponectin in the rat testis. Endocrinology 2008, 149(7):3390-3402.
35. Canoy D., Wareham N., Welch A., Bingham S., Luben R., Day N., et al. Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. The American Journal of Clinical Nutrition 2005, 82:1203-1209.
36. Cantorna M.T., Mahon B.D. D-hormone and the immune system. The Journal of Rheumatology 2005, 76:11-20.
37. Cardillo S., Seshadri P., Iqbal N. The effects of a low carbohydrate versus low-fat diet on adipocytokines in severely obese adults: Three-year follow-up of a randomized trial. European Review for Medical and Pharmacological Sciences 2006, 10:99-106.
38. Carvalho C.R., Bueno A.A., Mattos A.M., Biz C., de Oliveira C., Pisani L.P., et al. Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes. Nutrition Research 2010, 30(9):644-649.
39. Carvallo L., Henriquez B., Olate J., van Wijnen A.J., Lian J.B., Stein G.S., et al. The 1alpha,25-dihydroxy Vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene. The Journal of Steroid Biochemistry and Molecular Biology 2007, 103(3-5):420-424.
40. Chabrolle C., Tosca L., Dupont J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction 2007, 133:719-731.
41. Chalvatzas N., Dafopoulos K., Kosmas G., Kallitsaris A., Pournaras S., Messinis I.E. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertility and Sterility 2009, 91(4):1189-1194.
42. Chen X., Sebastian B.M., Nagy L.E. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. American Journal of Physiology. Endocrinology and Metabolism 2007, 292:621-628.
43. Chidakel A., Mentuccia D., Celi F.S. Peripheral metabolism of thyroid hormone and glucose homeostasis. Thyroid 2005, 15(8):899-903.
44. Chinetti G., Zawadski C., Fruchart J.C., Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARa, PPARg, and LXR. Biochemical and Biophysical Research Communications 2004, 314:151-158.
45. Cho S.Y., Park P.J., Shin H.J., Kim Y.K., Shin D.W., Shin E.S., et al. (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells. American Journal of Physiology. Endocrinology and Metabolism 2007, 292(4):1166-1172.
46. Chu C.H., Lam H.C., Lee J.K., Lu C.C., Sun C.C., Wang M.C., et al. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels. Journal of Thyroid Research 2011, 2011:194721. 10.4061/2011/194721.
47. Civitarese A.E., Carling S., Heilbronn L.K., Hulver M.H., Ukropcova B., Deutsch W.A., et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Medicine 2007, 4:e76.
48. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. The Journal of Clinical Investigation 2001, 108:1875-1881.
49. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003, 52(2):268-276.
50. Combs T.P., Pajvani U.B., Berg A.H., Lin Y., Jelicks L.A., Laplante M., et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004, 145(1):367-383.
51. Costacou T., Ma B., King I.B., Mayer-Davis E.J. Plasma and dietary vitamin E in relation to insulin secretion and sensitivity. Diabetes, Obesity & Metabolism 2008, 10(3):223-228.
52. Crawford L.J., Peake R., Price S., Morris T.C., Irvine A.E. Adiponectin is produced by lymphocytes and is a negative regulator of granulopoiesis. Journal of Leukocyte Biology 2010, 88(4):807-811.
53. Dafopoulos K., Sourlas D., Kallitsaris A., Pournaras S., Messinis I.E. Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle. Fertility and Sterility 2009, 92(4):1389-1394.
54. de Luis D.A., Aller R., Izaola O., Gonzalez-Sagrado M., Bellioo D., Conde R. Effects of a low-fat versus a low-carbohydrate diet on adipocytokines in obese adults. Hormone Research 2007, 67:296-300.
55. de Oliveira C., Iwanaga-Carvalho C., Mota J.F., Oyama L.M., Ribeiro E.B., Oller do Nascimento C.M. Effects of adrenal hormones on the expression of adiponectin and adiponectin receptors in adipose tissue, muscle and liver. Steroids 2011, 76(12):1260-1267.
56. de Oliveira C., Mattos A.B.M., Biz C., Oyama L.M., Ribeiro E.B., Nascimento C.M. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations. Lipids in Health and Disease 2011, 10:11.
57. Degawa-Yamauchi M., Moss K.A., Bovenkerk J.E., Shankar S.S., Morrison C.L., Lelliott C.J., et al. Regulation of adiponectin expression in human adipocytes: Effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obesity Research 2005, 13(4):662-669.
58. Delaigle A.M., Jonas J.C., Bauche I.B., Cornu O., Brichard S.M. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004, 145:5589-5597.
59. Dimitriadis G.D., Raptis S.A. Thyroid hormone excess and glucose intolerance. Experimental and Clinical Endocrinology & Diabetes 2001, 109(Suppl. 2):225-239.
60. Dominici F.P., Argentino D.P., Muñoz M.C., Miquet J.G., Sotelo A.I., Turyn D. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Hormone & IGF Research 2005, 15(5):324-336.
61. Donovan D.S., Solomon C.G., Seely E.W., Williams G.H., Simonson D.C. Effect of sodium intake on insulin sensitivity. The American Journal of Physiology 1993, 264(5 Pt 1):730-734.
62. Duntas L.H. Thyroid disease and lipids. Thyroid 2002, 12(4):287-293.
63. Edén Engström B., Burman P., Holdstock C., Karlsson F.A. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. The Journal of Clinical Endocrinology and Metabolism 2003, 88:5193-5198.
64. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. The American Journal of Clinical Nutrition 2002, 76:911-922.
65. Fallo F., Scarda A., Sonino N., Paoletta A., Boscaro M., Pagano C., et al. Effect of glucocorticoids on adiponectin: A study in healthy subjects and in Cushing's syndrome. European Journal of Endocrinology 2004, 150(3):339-344.
66. Fasshauer M., Klein J., Kralisch S., Klier M., Lössner U., Blüher M., et al. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Letters 2004, 558(1-3):27-32.
67. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Letters 2001, 507:142-146.
68. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2002, 290(3):1084-1089.
69. Fernández-Real J.M., López-Bermejo A., Casamitjana R., Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. The Journal of Clinical Endocrinology and Metabolism 2003, 88(6):2714-2718.
70. Fernández-Real J.M., Vendrell J., Ricart W. Circulating adiponectin and plasma fatty acid profile. Clinical Chemistry 2005, 51:603-609.
71. Flachs P., Mohamed-Ali V., Horakova O., Rossmeisl M., Hosseinzadeh-Attar M.J., Hensler M., et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006, 49(2):394-397.
72. Frank S.J. Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm IGF Res 2001, 11(4):201-212.
73. Freedman M.R., Stern J.S., Reaven G.M., Mondon C.E. Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats. Hormone and Metabolic Research 1986, 18:296-298.
74. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(4):2005-2010.
75. Fu L., Isobe K., Zeng Q., Suzukawa K., Takekoshi K., Kawakami Y. Beta adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-alpha expression in adipocytes. European Journal of Pharmacology 2007, 569(1-2):155-162.
76. Fuenmayor N., Moreira E., Cubeddu L.X. Salt sensitivity is associated with insulin resistance in essential hypertension. American Journal of Hypertension 1998, 11(4 Pt 1):397-402.
77. Fujimoto N., Matsuo N., Sumiyoshi H., Yamaguchi K., Saikawa T., Yoshimatsu H., et al. Adiponectin is expressed in the brown adipose tissue and surrounding immature tissues in mouse embryos. Biochimica et Biophysica Acta 2005, 1731(1):1-12.
78. Fujioka D., Kawabata K., Saito Y., Kobayashi T., Nakamura T., Kodama Y., et al. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. American Journal of Physiology. Heart and Circulatory Physiology 2006, 290(6):2409-2416.
79. Fukumitsu S., Aida K., Ueno N., Ozawa S., Takahashi Y., Kobori M. Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. The British Journal of Nutrition 2008, 100:669-676.
80. Furuhashi M., Ura N., Higashiura K., Murakami H., Tanaka M., Moniwa N., et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42(1):76-81.
81. Gannagé-Yared M.H., Chedid R., Khalife S., Azzi E., Zoghbi F., Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. European Journal of Endocrinology 2009, 160(6):965-971.
82. Gavrila A., Chan J.L., Yiannakouris N., Kontogianni M., Miller L.C., Orlova C., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies. The Journal of Clinical Endocrinology and Metabolism 2003, 88:4823-4831.
83. Gavrila A., Peng C.K., Chan J.L., Mietus J.E., Goldberger A.L., Mantzoros C.S. Diurnal and ultradian dynamics of serum adiponectin in healthy men: Comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. Journal of Clinical Endocrinology and Metabolism 2003, 88:2838-2843.
84. Gray B., Swick J., Ronnenberg A.G. Vitamin E and adiponectin: Proposed mechanism for vitamin E-induced improvement in insulin sensitivity. Nutrition Reviews 2011, 69(3):155-161.
85. Ha S.K., Kim J., Chae C. Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats. Journal of Comparative Pathology 2011, 145(1):88-94.
86. Hada Y., Yamauchi T., Waki H., Tsuchida A., Hara K., Yago H., et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochemical and Biophysical Research Communications 2007, 356:487-493.
87. Halleux C.M., Takahashi M., Delporte M.L., Detry R., Funahashi T., Matsuzawa Y., et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochemical and Biophysical Research Communications 2001, 288(5):1102-1107.
88. Hana V., Silha J.V., Justova V., Lacinova Z., Stepan J.J., Murphy L.J. The effects of GH replacement in adult GH-deficient patients: Changes in body composition without concomitant changes in the adipokines and insulin resistance. Clinical Endocrinology 2004, 60(4):442-450.
89. Hernandez-Morante J.J., Milagro F.I., Larque E., Lujan J., Martinez J.A., Zamora S., et al. Relationship among adiponectin, adiponectin gene expression and fatty acids composition in morbidly obese patients. Obesity Surgery 2007, 17:516-524.
90. Hew F.L., Koschmann M., Christopher M., Rantzau C., Vaag A., Ward G., et al. Insulin resistance in growth hormone-deficient adults: Defects in glucose utilization and glycogen synthase activity. The Journal of Clinical Endocrinology and Metabolism 1996, 81:555-564.
91. Higdon J.V., Frei B. Coffee and health: A review of recent human research. Critical Reviews in Food Science and Nutrition 2006, 46(2):101-123.
92. Hong S.C., Yoo S.W., Cho G.J., Kim T., Hur J.Y., Park Y.K., et al. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 2007, 14(5):835-840.
93. Horenburg S., Fischer-Posovszky P., Debatin K.M., Wabitsch M. Influence of sex hormones on adiponectin expression in human adipocytes. Hormone and Metabolic Research 2008, 40(11):779-786.
94. Hsieh C.J., Wang P.W. Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function. Endocrine Journal 2008, 55(3):489-494.
95. Hug C., Wang J., Ahmad N.S., Bogan J.S., Tsao T.S., Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(28):10308-10313.
96. Iglesias P., Alvarez Fidalgo P., Codoceo R., Díez J.J. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology 2003, 59(5):621-629.
97. Iglesias P., Díez J.J. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 2007, 40(2):61-70.
98. Imatoh T., Tanihara S., Miyazaki M., Momose Y., Uryu Y., Une H. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. European Journal of Nutrition 2011, 50(4):279-284.
99. Imhof A., Plamper I., Maier S., Trischler G., Koenig W.I. Effect of drinking on adiponectin in healthy men and women: A randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care 2009, 32:1101-1103.
100. Ingelson E., Arnlov J., Zethelius B., Vasan R.S., Flyvbjerg A., Frystyk J., et al. Associations of serum adiponectin with skeletal muscle morphology and insulin sensitivity. Endocrinology and Metabolism 2009, 94:953-957.
101. Iso H., Date C., Wakai K., Fukui M., Tamakoshi A. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Annals of Internal Medicine 2006, 144(8):554-562.
102. Itoh M., Suganami T., Satoh N., Tanimoto-Koyama K., Yuan X., Tanaka M., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:1918-1925.
103. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52(7):1655-1663.
104. Jang C., Inder W.J., Obeyesekere V.R., Alford F.P. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clinical Endocrinology 2008, 69(5):745-750.
105. Joaquin C., Aguilera E., Granada M.L., Pastor M.C., Salinas I., Alonso N., et al. Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A. European Journal of Endocrinology 2008, 158(4):483-490.
106. Johnston C.S., Beezhold B.L., Mostow B., Swan P.D. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. The Journal of Nutrition 2007, 137(7):1757-1762.
107. Joosten M.M., Beulens J.W., Kersten S., Hendriks H.F. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: A randomised, crossover trial. Diabetologia 2008, 51:1375-1381.
108. Joosten M.M., Chiuve S.E., Mukamal K.J., Hu F.B., Hendriks H.F., Rimm E.B. Changes in alcohol consumption and subsequent risk of type 2 diabetes in men. Diabetes 2011, 60:74-79.
109. Jürimäe J., Jürimäe T. Plasma adiponectin concentration in healthy pre and postmenopausal women: Relationship with body composition, bone mineral, and metabolic variables. American Journal of Physiology. Endocrinology and Metabolism 2007, 293(1):42-47.
110. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005, 26:439-451.
111. Kamari Y., Shimoni N., Koren F., Peleg E., Sharabi Y., Grossman E. High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: The role of the renin-angiotensin-aldosterone system. Journal of Hypertension 2010, 28(1):95-101.
112. Karbowska J., Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochemical Pharmacology 2005, 70(2):249-257.
113. Katsuki A., Suematsu M., Gabazza E.C., Murashima S., Nakatani K., Togashi K., et al. Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 2006, 29(10):2327-2328.
114. Kawamoto R., Kohara K., Tabara Y., Miki T., Ohtsuka N., Kusunoki T., et al. Alcohol consumption is associated with decreased insulin resistance independent of body mass index in Japanese community-dwelling men. The Tohoku Journal of Experimental Medicine 2009, 218:331-337.
115. Kempf K., Herder C., Erlund I., Kolb H., Martin S., Carstensen M., et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: A clinical trial. The American Journal of Clinical Nutrition 2010, 91(4):950-957.
116. Keogh J.B., Brinkworth G.D., Clifton P.M. Effects of weight loss on a low carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. The British Journal of Nutrition 2007, 98:852-859.
117. Keogh J.B., Brinkworth G.D., Noakes M., Belobrajdic D.P., Buckley J.D., Clifton P.M. Effects of weight loss from a very-lowcarbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. The American Journal of Clinical Nutrition 2008, 87:567-576.
118. Kharroubi I., Rasschaert J., Eizirik D.L., Cnop M. Expression of adiponectin receptors in pancreatic beta cells. Biochemical and Biophysical Research Communications 2003, 312:1118-1122.
119. Kleiblová P., Springer D., Haluzík M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiological Research 2006, 55(6):661-666.
120. Kokkinos A., Mourouzis I., Kyriaki D., Pantos C., Katsilambros N., Cokkinos D.V. Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocrine 2007, 32(1):30-32.
121. Koppes L.L., Dekker J.M., Hendriks H.F., Bouter L.M., Heine R.J. Moderate alcohol consumption lowers the risk of type 2 diabetes: A meta-analysis of prospective observational studies. Diabetes Care 2005, 28:719-725.
122. Kotani K., Fujiwara S., Hamada T., Tsuzaki K., Sakane N. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: Response to Williams et al. Diabetes Care 2008, 31(5):46-47.
123. Krikken J.A., Dallinga-Thie G.M., Navis G., Dullaart R.P. Short term dietary sodium restriction decreases HDL cholesterol, apolipoprotein A-I and high molecular weight adiponectin in healthy young men: Relationships with renal hemodynamics and RAAS activation. Nutrition, Metabolism, and Cardiovascular Diseases 2012, 22:35-41.
124. Lam K.S., Xu A., Tan K.C., Wong L.C., Tiu S.C., Tam S. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. The Journal of Clinical Endocrinology and Metabolism 2004, 89(11):5448-5453.
125. Landrier J.F., Gouranton E., El Yazidi C., Malezet C., Balaguer P., Borel P., et al. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Endocrinology 2009, 150(12):5318-5325.
126. Lanes R., Soros A., Gunczler P., Paoli M., Carrillo E., Villaroel O., et al. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins. The Journal of Pediatrics 2006, 149(3):324-329.
127. Lara-Castro C., Luo N., Wallace P., Klein R.L., Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249-259.
128. Lee M.S., Kim C.T., Kim Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Annals of Nutrition & Metabolism 2009, 54(2):151-157.
129. Lee S., Lee D.K., Choi E., Lee J.W. Identification of a functional vitamin D response element in themurine Insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes. Molecular Endocrinology 2005, 19:399-408.
130. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130(3):456-469.
131. Lely A.T., Krikken J.A., Bakker S.J., Boomsma F., Dullaart R.P., Wolffenbuttel B.H., et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. The Journal of Clinical Endocrinology and Metabolism 2007, 92(5):1821-1826.
132. Lewandowski K., Szosland K., Lewinski A. Short-term dexamethasone administration does not alter serum adiponectin or resistin concentrations in overweight and obese subjects despite an increase in insulin resistance. Clinical Endocrinology 2006, 65:551-552.
133. Li R.W., Douglas T.D., Maiyoh G.K., Adeli K., Theriault A.G. Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster model. Journal of Ethnopharmacology 2006, 104(1-2):24-31.
134. Li P., Sun F., Cao H.M., Ma Q.Y., Pan C.M., Ma J.H., et al. Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: Adiponectin regulates steroidogenesis. Biochemical and Biophysical Research Communications 2009, 390(4):1208-1213.
135. Liang X., Hu M., Rogers C.Q., Shen Z., You M. Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice. Antioxidants & Redox Signaling 2011, 15(2):425-435.
136. Libe R., Morpurgo P.S., Cappiello V., Maffini A., Bondioni S., Locatelli M., et al. Ghrelin and adiponectin in patients with Cushing's disease before and after transsphenoidal surgery. Clinical Endocrinology 2005, 62:30-36.
137. Lihn A.S., Bruun J.M., He G., Pedersen S.B., Jensen P.F., Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Molecular and Cellular Endocrinology 2004, 219:9-15.
138. Lihn A.S., Pedersen S.B., Richelsen B. Adiponectin: Action, regulation and association to insulin sensitivity. Obesity Reviews 2005, 6:13-21.
139. Lin S.Y., Huang S.C., Sheu W.H. Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal. Metabolism 2010, 59(2):195-199.
140. Liu E., Meigs J.B., Pittas A.G., McKeown N.M., Economos C.D., Booth S.L., et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. The Journal of Nutrition 2009, 139(2):329-334.
141. Loustis K., Pontikides N., Koliakos G., Constantinidis T.H., Papadopoulou F., Krassas G.E. Serum cytokines profile in Graves' hyperthyroidism before and after restoration of thyroid function: Correlation with different anthropometric parameters 2006, P143, 96.
142. Luvizotto R.A., Síbio M.T., Olímpio R.M., Nascimento A.F., Lima-Leopoldo A.P., Leopoldo A.S., et al. Supraphysiological triiodothyronine doses diminish leptin and adiponectin gene expression, but do not alter resistin expression in calorie restricted obese rats. Hormone and Metabolic Research 2011, 43(7):452-457.
143. Ma H., Gomez V., Lu L., Yang X., Wu X., Xiao S.Y. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2009, 24(2):233-237.
144. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochemical and Biophysical Research Communications 1996, 221(2):286-289.
145. Makimura H., Mizuno T.M., Bergen H., Mobbs C.V. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. American Journal of Physiology. Endocrinology and Metabolism 2002, 283:E1266-E1271.
146. Matsunami T., Sato Y., Ariga S., Sato T., Shimomura T., Kashimura H., et al. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Metabolism 2011, 60:805-814.
147. Meeprom A., Sompong W., Suwannaphet W., Yibchok-anun S., Adisakwattana S. Grape seed extract supplementation prevents high-fructose diet-induced insulin resistance in rats by improving insulin and adiponectin signalling pathways. The British Journal of Nutrition 2011, 106:1173-1181.
148. Mezey E. Dietary fat and alcoholic liver disease. Hepatology 1998, 28:901-905.
149. Mitsiades N., Pazaitou-Panayiotou K., Aronis K.N., Moon H.S., Chamberland J.P., Liu X., et al. Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism 2011, 96:E2023-E2028. 10.1210/jc.2010-1908.
150. Montonen J., Knekt P., Järvinen R., Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004, 27(2):362-366.
151. Motoshima H., Wu X., Mahadev K., Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochemical and Biophysical Research Communications 2004, 315:264-271.
152. Mullen K.L., Tishinsky J.M., Robinson L.E., Dyck D.J. Skeletal muscle inflammation is not responsible for the rapid impairment in adiponectin response with high-fat feeding in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2010, 299:500-508.
153. Müssig K., Remer T., Maser-Gluth C. Brief review: Glucocorticoid excretion in obesity. The Journal of Steroid Biochemistry and Molecular Biology 2010, 121(3-5):589-593.
154. Nagasaki T., Inaba M., Hiura Y., Tahara H., Kumeda Y., Shirakawa K., et al. Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy. Biomedicine & Pharmacotherapy 2005, 59(10):571-577.
155. Nakandakare E.R., Charf A.M., Santos F.C., Nunes V.S., Ortega K., Lottenberg A.M., et al. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients. Atherosclerosis 2008, 200(2):410-416.
156. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., Tonita M. Isolation and characterization of GBP28, a novel gelatine-binding protein purified from human plasma. Journal of Biochemistry 1996, 120:803-812.
157. Nam S.Y., Lobie P.E. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obesity Reviews 2000, 1(2):73-86.
158. Nam S.Y., Marcus C. Growth hormone and adipocyte function in obesity. Hormone Research 2000, 53(Suppl. 1):87-97.
159. Nanji A.A., Sadrzadeh S.M., Yang E.K., Fogt F., Meydani M., Dannenberg A.J. Dietary saturated fatty acids: A novel treatment for alcoholic liver disease. Gastroenterology 1995, 109:547-554.
160. Neschen S., Morino K., Dong J., Wang-Fischer Y., Cline G.W., Romanelli A.J., et al. ω-3 fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes 2007, 56:1034-1041.
161. Neschen S., Morino K., Rossbacher J.C., Pongratz R.L., Cline G.W., Sono S., et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 2006, 55:924-928.
162. Nilsson L., Binart N., Bohlooly-Y M., Bramnert M., Egecioglu E., Kindblom J., et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochemical and Biophysical Research Communications 2005, 331(4):1120-1126.
163. Nimitphong H., Chanprasertyothin S., Jongjaroenprasert W., Ongphiphadhanakul B. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009, 36(2):205-210.
164. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51(9):2734-2741.
165. Oana F., Takeda H., Matsuzawa A., Akahane S., Isaji M., Akahane M. Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist. European Journal of Pharmacology 2005, 518(1):71-76.
166. Obregon M.J. Thyroid hormone and adipocyte differentiation. Thyroid 2008, 18(2):185-195.
167. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression inhuman monocyte-derived macrophages. Circulation 2001, 103:1057-1063.
168. Paniagua J.A., Gallego de la Sacristana A., Romero I., Vidal-Puig A., Latre J.M., Sanchez E., et al. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 2007, 30:1717-1723.
169. Panidis D., Kourtis A., Farmakiotis D., Mouslech T., Rousso D., Koliakos G. Serum adiponectin levels in women with polycystic ovary syndrome. Human Reproduction 2003, 18(9):1790-1796.
170. Paolisso G., D'Amore A., Giugliano D., Ceriello A., Varricchio M., D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. The American Journal of Clinical Nutrition 1993, 57(5):650-656.
171. Paschke L., Zemleduch T., Rucinski M., Ziolkowska A., Szyszka M., Malendowicz L.K. Adiponectin and adiponectin receptor system in the rat adrenal gland: Ontogenetic and physiologic regulation, and its involvement in regulating adrenocortical growth and steroidogenesis. Peptides 2010, 31(9):1715-1724.
172. Patel J.V., Cummings D.E., Girod J.P., Mascarenhas A.V., Hughes E.A., Gupta M., et al. Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment. Journal of Negative Results in Biomedicine 2006, 5:14.
173. Peng Y., Rideout D., Rakita S., Sajan M., Farese R., You M., et al. Downregulation of adiponectin/adipoR2 is associated with steatohepatitis in obese mice. Journal of Gastrointestinal Surgery 2009, 13:2043-2049.
174. Peres de Heredia F., Sanchez J., Priego T., Larque E., del Puy Portillo M., Palou A., et al. Adiponectin is associated with serum and adipose tissue fatty acid composition in rats. Journal of Endocrinological Investigation 2009, 32:659-665.
175. Pérez-de-Heredia F., Sánchez J., Priego T., Nicolás F., Portillo Mdel P., Palou A., et al. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Steroids 2008, 73(11):1128-1136.
176. Pineiro R., Iglesias M.J., Gallego R., Raghay K., Eiras S., Rubio J., et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Letters 2005, 579:5163-5169.
177. Pischon T., Girman C.J., Rifai N., Hotamisligil G.S., Rimm E.B. Association between dietary factors and plasma adiponectin concentrations in men. The American Journal of Clinical Nutrition 2005, 81:780-786.
178. Potenza M.A., Marasciulo F.L., Tarquinio M., Tiravanti E., Colantuono G., Federici A., et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. American Journal of Physiology. Endocrinology and Metabolism 2007, 292(5):1378-1387.
179. Psilopanagioti A., Papadaki H., Kranioti E.F., Alexandrides T.K., Varakis J.N. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 2009, 89:38-47.
180. Pucci E., Chiovato L., Pinchera A. Thyroid and lipid metabolism. International Journal of Obesity and Related Metabolic Disorders 2000, 24(Suppl. 2):S109-S112.
181. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., et al. Adiponectin acts in the brain to decrease body weight. Nature Medicine 2004, 10:524-529.
182. Qiao L., Lee B., Kinney B., Yoo H.S., Shao J. Energy intake and adiponectin gene expression. American Journal of Physiology. Endocrinology and Metabolism 2011, 300(5):809-816.
183. Qin B., Polansky M.M., Anderson R.A. Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose fed rats. Hormone and Metabolic Research 2010, 42:187-193.
184. Qin Y., Tian Y.P. Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels. Molecular Medicine Reports 2010, 3(3):525-530.
185. Rasmussen M.S., Lihn A.S., Pedersen S.B., Bruun J.M., Rasmussen M., Richelsen B. Adiponectin receptors in human adipose tissue: Effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) 2006, 14:28-35.
186. Repunte-Canonigo V., Berton F., Cottone P., Reifel-Miller A., Roberts A.J., Morales M., et al. A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intake. Brain Research 2010, 1339:11-17.
187. Rieth N., Jollin L., Le Panse B., Lecoq A.M., Arlettaz A., De Ceaurriz J., et al. Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men. European Journal of Applied Physiology 2009, 105(2):309-313.
188. Rodriguez-Pacheco F., Martinez-Fuentes A.J., Tovar S., Pinilla L., Tena-Sempere M., Dieguez C., et al. Regulation of pituitary cell function by adiponectin. Endocrinology 2007, 148:401-410.
189. Rose F.J., Webster J., Barry J.B., Phillips L.K., Richards A.A., Whitehead J.P. Synergistic effects of ascorbic acid and thiazolidinedione on secretion of high molecular weight adiponectin from human adipocytes. Diabetes, Obesity & Metabolism 2010, 12:1084-1089.
190. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: Direct and indirect effects of tumor necrosis factor-alpha. Cytokine & Growth Factor Reviews 2003, 14:447-455.
191. Ryan A.S., Berman D.M., Nicklas B.J., Sinha M., Gingerich R.L., Meneilly G.S., et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003, 26:2383-2388.
192. Saito T., Kawano T., Saito T., Ikoma A., Namai K., Tamemoto H., et al. Elevation of serum adiponectin levels in Basedow disease. Metabolism 2005, 54(11):1461-1466.
193. Santini F., Marsili A., Mammoli C., Valeriano R., Scartabelli G., Pelosini C., et al. Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. Journal of Endocrinological Investigation 2004, 27(2):RC5-RC7.
194. Sayinalp S., Gedik O., Koray Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcified Tissue International 1995, 57(6):422-425.
195. Seow K.M., Tsai Y.L., Juan C.C., Lin Y.H., Hwang J.L., Ho L.T. Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: A preliminary study. Reproductive Biomedicine Online 2009, 19(4):577-582.
196. Shen X.H., Tang Q.Y., Huang J., Cai W. Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity. Experimental Biology and Medicine (Maywood, N.J.) 2010, 235(1):47-51.
197. Shimada M., Mochizuki K., Sakurai N., Goda T. Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats. Bioscience, Biotechnology, and Biochemistry 2007, 71(8):2079-2082.
198. Shirai N., Suzuki H. Effects of simultaneous intakes of fish oil and green tea extracts on plasma, glucose, insulin, C-peptide, and adiponectin and on liver lipid concentrations in mice fed low- and high-fat diets. Annals of Nutrition & Metabolism 2008, 52(3):241-249.
199. Shoupe D., Lobo R.A. The influence of androgens on insulin resistance. Fertility and Sterility 1984, 41:385-388.
200. Sieminska L., Niedziolka D., Pillich A., Kos-Kudla B., Marek B., Nowak M., et al. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients. Journal of Endocrinological Investigation 2008, 31(9):745-749.
201. Siemińska L., Wojciechowska C., Kos-Kudła B., Marek B., Kajdaniuk D., Nowak M., et al. Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto's thyroiditis. Endokrynologia Polska 2010, 61(1):112-116.
202. Sierksma A., Patel H., Ouchi N., Kihara S., Funahashi T., Heine R.J., et al. Effect of moderate alcohol consumption on adiponectin, TNF-alpha, and insulin sensitivity. Diabetes Care 2004, 27:184-189.
203. Silha J.V., Krsek M., Hana V., Marek J., Jezkova J., Weiss V., et al. Perturbations in adiponectin, leptin and resistin levels in acromegaly: Lack of correlation with insulin resistance. Clinical Endocrinology 2003, 58(6):736-742.
204. Soares A.F., Guichardant M., Cozzone D., Bernoud-Hubac N., Bouzaidi-Tiali N., Lagarde M., et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radical Biology & Medicine 2005, 38:882-889.
205. Song Z., Zhou Z., Deaciuc I., Chen T., McClain C.J. Inhibition of adiponectin production by homocysteine: A potential mechanism for alcoholic liver disease. Hepatology 2008, 47:867-879.
206. Spranger J., Möhlig M., Wegewitz U., Ristow M., Pfeiffer A.F., Schill T., et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology 2004, 61(6):738-746.
207. Steyn F.J., Boehme F., Vargas E., Wang K., Parkington H.C., Rao J.R., et al. Adiponectin regulate growth hormone secretion via adiponectin receptor mediated Ca(2+) signalling in rat somatotrophs in vitro. Journal of Neuroendocrinology 2009, 21(8):698-704.
208. Sun X., Han R., Wang Z., Chen Y. Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Diabetologia 2006, 49(6):1303-1310.
209. Takemura Y., Osuga Y., Yamauchi T., Kobayashi M., Harada M., Hirata T., et al. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 2006, 147(7):3203-3210.
210. Tamakoshi K., Yatsuya H., Wada K., Matsushita K., Otsuka R., Yang P.O., et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clinical Endocrinology 2007, 66:65-71.
211. Tan B.K., Chen J., Digby J.E., Keay S.D., Kennedy C.R., Randeva H.S. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia 2006, 49(11):2723-2728.
212. Tanaka K., Inoue S., Numata K., Okazaki H., Nakamura S., Takamura Y. Very low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-Dopa in obesity. Metabolism 1990, 39:892-896.
213. Tang H., Sebastian B.M., Axhemi A., Chen X., Hillian A.D., Jacobsen D.W., et al. Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcoholism, Clinical and Experimental Research 2012, 36:214-222. 10.1111/j.1530-0277.2011.01607.x.
214. Tappy L., Lê K.A., Tran C., Paquot N. Fructose and metabolic diseases: New findings, new questions. Nutrition 2010, 26(11-12):1044-1049.
215. Thamer C., Haap M., Fritsche A., Haering H., Stumvoll M. Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care 2004, 27(5):1240.
216. Trayhurn P., Wang B., Wood I.S. Hypoxia and the endocrine and signalling role of white adipose tissue. Archives of Physiology and Biochemistry 2008, 114(4):267-276.
217. Tworoger S.S., Mantzoros C., Hankinson S.E. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity (Silver Spring) 2007, 15(9):2217-2224.
218. Usukura M., Zhu A., Yoneda T., Karashima S., Yagi K., Yamagishi M., et al. Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats. Steroids 2009, 74(12):978-982.
219. Van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA: The Journal of the American Medical Association 2005, 294(1):97-104.
220. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Current Opinion in Lipidology 2003, 14:15-19.
221. Viengchareun S., Zennaro M.C., Pascual-Le Tallec L., Lombes M. Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. FEBS Letters 2002, 532(3):345-350.
222. Vincent H.K., Bourguignon C.M., Weltman A.L., Vincent K.R., Barrett E., Innes K.E., et al. Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism 2009, 58(2):254-262.
223. Vitaglione P., Morisco F., Mazzone G., Amoruso D.C., Ribecco M.T., Romano A., et al. Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010, 52(5):1652-1661.
224. Wang Q., Guo T., Tao Y., Wang Q., Song Y., Huang W. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome. Gynecological Endocrinology 2011, 27(11):931-934.
225. Wang Y., Lam K., Yau M., Xu A. Post-translational modifications of adiponectin: Mechanisms and functional implications. The Biochemical Journal 2008, 409:623-633.
226. Wedick N.M., Brennan A.M., Sun Q., Hu F.B., Mantzoros C.S., van Dam R.M. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: A randomized controlled trial. Nutrition Journal 2011, 10:93.
227. Williams C.J., Fargnoli J.L., Hwang J.J., van Dam R.M., Blackburn G.L., Hu F.B., et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: A prospective cohort study. Diabetes Care 2008, 31(3):504-507.
228. Wölfing B., Neumeier M., Buechler C., Aslanidis C., Schölmerich J., Schäffler A. Interfering effects of insulin, growth hormone and glucose on adipokine secretion. Experimental and Clinical Endocrinology & Diabetes 2008, 116(1):47-52.
229. Wu A.H., Yu M.C., Stanczyk F., Tseng C.C., Pike M.C. Anthropometric, dietary and hormonal correlates of serum adiponectin in Asian American women. Nutrition and Cancer 2011, 63(4):549-557.
230. Xi L., Qian Z., Xu G., Zheng S., Sun S., Wen N., et al. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. The Journal of Nutritional Biochemistry 2007, 18(1):64-72.
231. Xu A., Chan K.W., Hoo R.L., Wang Y., Tan K.C., Zhang J., et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. The Journal of Biological Chemistry 2005, 280:18073-18080.
232. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. The Journal of Clinical Investigation 2003, 112:91-100.
233. Xu A., Wong L.C., Wang Y., Xu J.Y., Cooper G.J., Lam K.S. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Letters 2004, 572(1-3):129-134.
234. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science (London, England) 2002, 103:137-142.
235. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
236. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. The Journal of Biological Chemistry 2001, 276(44):41245-41254.
237. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Medicine 2007, 13(3):332-339.
238. Yannakoulia M., Yiannakouris N., Melistas L., Fappa E., Vidra N., Kontogianni M.D., et al. Dietary factors associated with plasma high molecular weight and total adiponectin levels in apparently healthy women. European Journal of Endocrinology 2008, 159(4):5-10.
239. Yaturu S., Prado S., Grimes S.R. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. Journal of Cellular Biochemistry 2004, 93(3):491-496.
240. Yilmaz M., Bukan N., Demirci H., Oztürk C., Kan E., Ayvaz G., et al. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecological Endocrinology 2009, 25(4):246-252.
241. Yoda M., Nakano Y., Tobe T., Shioda S., Choi-Miura N.H., Tomita M. Characterization of mouse GBP28 and its induction by exposure to cold. International Journal of Obesity and Related Metabolic Disorders 2001, 25(1):75-83.
242. You M., Considine R.V., Leone T.C., Kelly D.P., Crabb D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005, 42(3):568-577.
243. Yu H., Yang Y., Zhang M., Lu H., Zhang J., Wang H., et al. Thyroid status influence on adiponectin, acylation stimulating protein ASP and complement C3 in hyperthyroid and hypothyroid subjects. Nutrition & Metabolism (London) 2006, 3:13.
244. Zhang H., Chen X., Aravindakshan J., Ram Sairam M. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: Implications for insulin resistance. Endocrinology 2007, 148:5667-5679.